Advertisement
U.S. markets close in 4 hours 6 minutes

Telesis Bio, Inc. (TBIO)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Visitors trend2W10W9M
0.8500-0.0600 (-6.59%)
As of 10:46AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.9100
Open0.8500
Bid0.7756 x 40000
Ask0.9100 x 300400
Day's Range0.8500 - 0.8500
52 Week Range0.8500 - 15.4620
Volume513
Avg. Volume1,404,682
Market Cap1.509M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-30.4200
Earnings DateNov 07, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Associated Press Finance

    Telesis Bio: Q3 Earnings Snapshot

    SAN DIEGO (AP) — Telesis Bio, Inc. TBIO) on Thursday reported a loss of $6.6 million in its third quarter. On a per-share basis, the San Diego-based company said it had a loss of $4.09.

  • GlobeNewswire

    Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis

    Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry CapabilitiesSAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create efficient and scalable biofoundries, delivering solutions for sustainable and rapid on-premise synthesis of DNA. This innovative approach enabled by Telesis Bio’s Gibson SOLA enzymatic reagent platform running on Beckman C